Lactobacillus iners vaginal
Selected indexed studies
- Contribution of Lactobacillus iners to Vaginal Health and Diseases: A Systematic Review. (Front Cell Infect Microbiol, 2021) [PMID:34881196]
- Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. (Microb Cell Fact, 2020) [PMID:33160356]
- Lactobacillus iners-dominated vaginal microbiota in pregnancy. (Ceska Gynekol, 2019) [PMID:31948257]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. (2022) pubmed
- Vaginal Lactobacillus fatty acid response mechanisms reveal a metabolite-targeted strategy for bacterial vaginosis treatment. (2024) pubmed
- Contribution of Lactobacillus iners to Vaginal Health and Diseases: A Systematic Review. (2021) pubmed
- Lactobacillus iners-dominated vaginal microbiota in pregnancy. (2019) pubmed
- Lactobacillus iners: Friend or Foe? (2017) pubmed
- Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. (2020) pubmed
- Vaginal microbiome of reproductive-age women. (2011) pubmed
- Characteristics associated with Lactobacillus iners-dominated vaginal microbiota. (2022) pubmed
- Lactobacillus iners and genital health: molecular clues to an enigmatic vaginal species. (2023) pubmed
- Strain-level variation among vaginal Lactobacillus crispatus and Lactobacillus iners as identified by comparative metagenomics. (2025) pubmed